Two of these discussed factors, thoughts and preferences to identify reasons for choosing GLP‐1 RAs as a medication when provided with several options, one with regard to diabetes management [38], and one weight‐loss (this being one of only two studies to use focus groups as a data collection method) [25]. This evidence concerns the gene GCG and diabetes mellitus.